Cheng Yenchieh - Regeneron Pharmaceuticals, Inc

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 14 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Intravitreal Aflibercept 8 Mg in Diabetic Macular Oedema (PHOTON): 48-Week Results from a Randomised, Double-Masked, Non-Inferiority, Phase 2/3 Trial

David M. Brown,David S. Boyer,Diana Do,Charles C. Wykoff,Taiji Sakamoto, Peter Win, Sunir Joshi,Hani Salehi-Had,Andras Seres,Alyson J. Berliner,Sergio Leal,Robert Vitti,Karen W. Chu,Kimberly Reed,Rohini Rao,Yenchieh Cheng, Wei Sun, Delia Voronca,Rafia Bhore,Ursula Schmidt-Ott,Thomas Schmelter,Andrea Schulze, Xin Zhang, Boaz Hirshberg,George Yancopoulos,Sobha Sivaprasad

LANCET（2024）

Cited0Views0WOSBibtex

Intravitreal Aflibercept 8 Mg in Neovascular Age-Related Macular Degeneration (PULSAR): 48-Week Results from a Randomised, Double-Masked, Non-Inferiority, Phase 3 Trial

LANCETno. 10432 (2024): 1141-1152

Cited0Views0WOSBibtex

Longitudinal Changes in Diabetic Retinopathy Severity: Learnings from PANORAMA

Charles C Wykoff, Diana V Do, W Lloyd Clark, David S Boyer, Dilsher S Dhoot, Dennis M Marcus, Robert Vitti, Alyson J Berliner,Kimberly Reed,Yenchieh Cheng,Hadi Moini, David M Brown

Ophthalmology Retina (2024)

Cited0Views0WOSBibtex

Intravitreal Nesvacumab (Anti-Angiopoietin-2) Plus Aflibercept in Neovascular AMD: Phase 2 ONYX Randomized Trial

Jeffrey S. Heier,Allen C. Ho,David S. Boyer,Karl Csaky,Robert Vitti,Lorah Perlee,Karen W. Chu,Friedrich Asmus,Sergio Leal,Oliver Zeitz,Yenchieh Cheng,Thomas Schmelter,David M. Brown

JOURNAL OF VITREORETINAL DISEASESno. 1 (2023): 8-15

Cited0Views0WOSBibtex

INTRAVITREAL NESVACUMAB (ANTIANGIOPOIETIN 2) PLUS AFLIBERCEPT IN DIABETIC MACULAR EDEMA: Phase 2 RUBY Randomized Trial

David M. Brown,David S. Boyer,Karl Csaky,Robert Vitti,Lorah Perlee,Karen W. Chu,Friedrich Asmus,Sergio Leal,Oliver Zeitz,Yenchieh Cheng,Thomas Schmelter,Jeffrey S. Heier

Retina（2022）

Cited9Views0WOSBibtex

Evaluation of Intravitreal Aflibercept for the Treatment of Severe Nonproliferative Diabetic Retinopathy: Results from the PANORAMA Randomized Clinical Trial

David M. Brown,Charles C. Wykoff,David Boyer,Jeffrey S. Heier,W. Lloyd Clark,Andres Emanuelli,Patrick M. Higgins,Michael Singer,David M. Weinreich,George D. Yancopoulos,Alyson J. Berliner,Karen Chu,Kimberly Reed,Yenchieh Cheng,Robert Vitti

JAMA ophthalmology（2021）

Cited64Views0WOSBibtex

Efficacy and Safety of Sarilumab for the Treatment of Posterior Segment Noninfectious Uveitis (SARIL-NIU):

Jarmila Heissigerová,David Callanan,Marc D. de Smet,Sunil K. Srivastava, Michala Karkanová,Olga Garcia-Garcia,Sibel Kadayifcilar,Yilmaz Ozyazgan,Robert Vitti,Kristine Erickson,Aditya Athanikar,Karen Chu,Namrata Saroj,Preethi A. Sundaram,Rafael Varona,Valerie Corp-dit-Genti,Ronald Buggage,Yenchieh Cheng,Yuhwen Soo,Quan Dong Nguyen

Ophthalmologyno. 3 (2019): 428-437

Cited43Views0Bibtex

Extended (every 12 Weeks or Longer) Dosing Interval with Intravitreal Aflibercept and Ranibizumab in Neovascular Age-Related Macular Degeneration: Post Hoc Analysis of VIEW Trials

Rahul N. Khurana,Ehsan Rahimy,W. Anthony Joseph,Namrata Saroj,Andrea Gibson,Robert Vitti,Alyson J. Berliner,Karen Chu,Yenchieh Cheng,David S. Boyer

American Journal of Ophthalmology（2019）

Cited28Views0WOSBibtex

Effects of Repeated Intravitreal Aflibercept Injection on the Corneal Endothelium in Patients with Age-Related Macular Degeneration: Outcomes from the RE-VIEW Study

Jonathan H. Lass,Beth Ann Benetz,Harry J. Menegay, Constantinos P. Tsipis, Jane Caty Cook,David S. Boyer,Michael Singer,Kristine Erickson,Namrata Saroj,Robert Vitti,Karen W. Chu,Hadi Moini,Yuhwen Soo,Yenchieh Cheng

Cornea（2018）

Cited9Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn